Introduction
============

Spectrin and ankyrin are associated with the cytoplasmic surface of the plasma membrane where they cooperate in micrometer-scale organization of membrane-spanning proteins within specialized membrane domains in many vertebrate tissues ([@bib5]; [@bib6]). A common organizational principle shared by spectrin/ankykrin-based domains, as presented in reviews and cartoons, is straightforward: membrane-spanning proteins, including cell adhesion proteins capable of responding to extracellular cues as well as membrane transporters, are "anchored" within the fluid bilayer by association with ankyrin, which in turn is coupled to an extended spectrin--actin network that is tightly associated with the plasma membrane ([@bib5]; [@bib6]). However, these protein-based models, although descriptive of steady-state protein composition, do not provide an explanation for how membrane domains are actually assembled and precisely localized in cells.

Membrane lipids and lipid modifications play important roles in determining plasma membrane identity. For example, phosphoinositide lipids are increasingly recognized as critical determinants of plasma membrane organization in addition to their roles in intracellular organelles ([@bib41]; [@bib54]; [@bib23]; [@bib33]; [@bib44]). In addition, the aspartate-histidine-histidine-cysteine (DHHC) family of 23 protein palmitoyltransferases, first discovered in yeast, now are known to function in vertebrates in targeting and trafficking of membrane proteins ([@bib2]; [@bib52]; [@bib16]; [@bib15]; [@bib22]). β-Spectrins contain a pleckstrin homology (PH) domain with preference for phosphatidylinositol 4,5-bisphosphate (PI(4,5)P~2~; [@bib58]; [@bib10]). Moreover, ankyrin-G is S-palmitoylated at a conserved cysteine (C70; [@bib24]). This palmitoylated cysteine is required for function of ankyrin-G in promoting formation of the lateral membrane of MDCK epithelial cells as well as assembly of axon initial segments in neurons ([@bib24]). Together, these considerations suggest the membrane lipid environment and in particular phosphoinositides and protein palmitoylation are likely to work in concert with ankyrin- and spectrin-based protein interactions in establishing and/or regulating membrane domains.

Ankyrin-G and βII-spectrin localize at the lateral membranes of columnar epithelial cells where deficiency of either protein results in reduced cell height as well as impaired reassembly of new lateral membrane after cytokinesis ([@bib34]; [@bib35]; [@bib32]). Ankyrin-G, in contrast to other lateral membrane--associated proteins, including its partners βII-spectrin and E-cadherin, persists on the plasma membrane of depolarized MDCK cells exposed to low calcium ([@bib24]). Ankyrin-G thus is a candidate to function as a template for the rapid restoration of the lateral membrane that occurs after readdition of calcium. Ankyrin-G retention on the plasma membrane of depolarized MDCK cells, as well as its function in maintaining lateral membrane height, both require a conserved cysteine residue that is S-palmitoylated ([@bib24]). These findings raise questions regarding the roles of palmitoyltransferases in directing polarized localization of ankyrin-G and βII-spectrin, as well as the functional hierarchy among these proteins in lateral membrane assembly.

The present study identifies DHHC5 and 8 as the only DHHC family members localized to the lateral membrane of MDCK cells and the two palmitoyltransferases responsible for palmitoylation and targeting of ankyrin-G. We also find that βII-spectrin requires binding to both ankyrin-G as well as PI(3,4)P~2~ and PI(3,4,5)P~3~ phosphoinositide lipids to localize and function at lateral membranes. βII-Spectrin thus operates as a coincidence detector that ensures high spatial fidelity in its polarized targeting to the lateral membrane. Together these findings demonstrate a critical requirement of palmitoylation and phosphoinositide recognition in addition to protein--protein interactions for precise assembly of ankyrin-G and βII-spectrin at the lateral membrane of epithelial cells.

Results
=======

DHHC5 and -8 are the physiological ankyrin-G palmitoyltransferases in MDCK cells
--------------------------------------------------------------------------------

We previously demonstrated that cysteine 70 of ankyrin-G is palmitoylated and is required for ankyrin-G function in formation of lateral membranes of MDCK cells and axon initial segments of hippocampal neurons ([@bib24]). We next sought to identify the palmitoyltransferases responsible for modifying ankyrin-G. A screening assay using metabolic labeling with \[^3^H\]palmitate in cells cotransfected with substrate and an individual member of the DHHC palmitoyltransferases has been widely used to determine enzyme specificity ([@bib16], [@bib17]; [@bib14]; [@bib31]; [@bib59]). Using this assay in HEK293T cells, we observed a dramatic increase of palmitoylation of ankyrin-G--GFP when coexpressed with either DHHC5 or 8, but not with the other 21 DHHC family members ([Fig. 1 A](#fig1){ref-type="fig"}).

![**Ankyrin-G is palmitoylated by palmitoyltransferases DHHC5 and -8.** (A) Ankyrin-G--GFP was cotransfected into HEK293 cells with each of the 23 HA-DHHC. After metabolic labeling with \[^3^H\]palmitic acid, cells were lysed and analyzed by SDS-PAGE. (top) The expression level of ankyrin-G--GFP probed by α-GFP antibody; (middle) autoradiograph showing the extent of protein labeling in cell extracts; (bottom) the expression level of the cotransfected HA-DHHC probed by α-HA antibody. (B) The phylogenetic tree of the 23 mouse DHHC shows that DHHC5 and -8 are closely related.](JCB_201401016_Fig1){#fig1}

A phylogenetic comparison of the 23 mouse DHHC proteins shows that DHHC5 and -8 are closely related ([Fig. 1 B](#fig1){ref-type="fig"}). DHHC5 and -8 use GRIP1b as a substrate in neurons and play critical roles in regulating AMPA-R trafficking ([@bib57]). Additionally, DHHC5 also directly palmitoylates flotillin-2 and is required for flotillin-2 oligomerization ([@bib37]). However, no study has characterized the biological functions of DHHC5 and -8 palmitoyltransferases in epithelial cells.

We next asked where DHHC5 and -8 are localized in MDCK cells, and whether these particular palmitoyltransferases exhibit a distinct pattern compared with the other 21 DHHC family members. Tagged DHHC proteins exhibit specific localization patterns in nonpolarized HEK293T cells ([@bib47]). However, the localization of DHHC proteins in epithelial cells has not been reported. 20 of the HA-DHHC constructs transfected into MDCK cells localized to intracellular compartments, most likely the Golgi--ER network as previously described ([@bib47]). However, DHHC5, 8, and 14 predominantly localized to the plasma membrane when viewed in XY sections ([Fig. 2 A](#fig2){ref-type="fig"}). The plasma membrane localization of DHHC8 and 14 in MDCK cells was unexpected because these proteins are primarily intracellular in HEK293T cells ([@bib47]). 3D confocal imaging in MDCK cells revealed that DHHC5 and -8 are polarized and confined to the lateral membrane together with ankyrin-G ([Fig. 2, B and C](#fig2){ref-type="fig"}). DHHC14, in contrast to DHHC5 and -8, localizes equally to both lateral and apical membranes ([Fig. 2 D](#fig2){ref-type="fig"}). DHHC5 and -8 thus are the only family members that colocalize with ankyrin-G on the lateral membranes of MDCK cells.

![**DHHC5 and -8 colocalize with ankyrin-G at lateral membranes of MDCK cells.** (A) HA-DHHC 1--23 were expressed in MDCK cells and visualized by immunofluorescence (red, α-HA; blue, DAPI). HA-DHHC5, 8, and 14 primarily localize to the plasma membrane, whereas the others exist in intracellular compartments. (B--D) GFP-tagged DHHC5, 8, or 14 were transfected into MDCK cells (green, α-GFP; red, α--ankyrin-G), and the XZ planes were reconstructed from confocal Z-stacks. Bars, 10 µm.](JCB_201401016_Fig2){#fig2}

We next asked whether DHHC5 and -8 were required for ankyrin-G palmitoylation in MDCK cells. We first confirmed that both DHHC5 and -8 are natively transcribed in cultured MDCK cells using RT-PCR ([Fig. 3 A](#fig3){ref-type="fig"}). Then we developed a cell-sorting strategy for generating doxycycline-inducible shRNA stable cell lines to study effects of knockdown of DHHC5 and -8, either separately or together. We modified the single lentiviral vector Tet-inducible shRNA system (pLKO-Tet-On; [@bib62]) in two ways: (1) the puromycin resistance gene was replaced with DNA encoding the fluorescent protein TagBFP (excite 402; emit 457) to allow fluorescent cell sorting without interfering with other fluorescent tags such as GFP or mCherry; (2) the internal ribosome entry site was replaced with a 2A "self-splicing" peptide linker to ensure that stimulation of shRNA expression also efficiently stimulated expression of TagBFP ([Fig. 3 B](#fig3){ref-type="fig"}). Through cell sorting, we were able to select a small population of cells with similar levels of shRNA expression ([Fig. 3 C](#fig3){ref-type="fig"}).

![**DHHC5 and -8 exhibit functional redundancy in palmitoylation of ankyrin-G.** (A) The RT-PCR shows that DHHC5 and -8 are natively transcribed in MDCK cells. (B and C) The cell sorting strategy for making inducible shRNA cell lines. P5 indicates the collected cell population (∼1%). (D--F) Single knockdown of DHHC5 or 8 shows no reduction of ankyrin-G palmitoylation. Endogenous ankyrin-G was immunoprecipitated and analyzed using acyl biotin exchange assay (D) or the silencing efficiency of DHHC5 (E) or 8 (F). (G--I) Double knockdown of DHHC5 and -8 causes significant reduction of ankyrin-G palmitoylation. (J) Quantification of the normalized ankyrin-G palmitoylation level; mean ± SEM. Results were analyzed using one-way ANOVA and Tukey's tests; \*, P \< 0.001; *n* = 3--5. (K) Quantification of DHHC5 and DHHC8 protein levels in Luc-, DHHC5-, and DHHC8-shRNA stable cell lines. Results were analyzed using one-way ANOVA and Tukey's tests; \*, P \< 0.001; *n* = 3.](JCB_201401016_Fig3){#fig3}

DHHC5 and -8 genes of *Canis lupus familiaris* share identical genomic sequences in multiple regions, which allow individual knockdown or selection of a single hairpin simultaneously targeting both genes in MDCK cells. An acyl-biotin exchange assay was used to assess ankyrin-G palmitoylation ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201401016/DC1){#supp1}; [@bib13]). Single knockdown of either DHHC5 or 8 had no effect on palmitoylation of ankyrin-G ([Fig. 3, D, E, F, and J](#fig3){ref-type="fig"}). We demonstrated this was not caused by up-regulation of one palmitoyltransferase after silencing the other one (Fig. S1 B and [Fig. 3 K](#fig3){ref-type="fig"}). However, silencing both DHHC5 and -8 markedly reduced ankyrin-G palmitoylation ([Fig. 3, G--J](#fig3){ref-type="fig"}). In summary, DHHC5 and -8 are the physiological palmitoyltransferases responsible for palmitoylating ankyrin-G in MDCK cells based on their unique behavior compared with the other 21 DHHC family members in palmitoylating ankyrin-G in heterologous cells, their colocalization with ankyrin-G at the lateral membranes of MDCK cells, as well as loss of ankyrin-G palmitoylation after their knockdown in MDCK cells.

DHHC5/8 double knockdown phenocopies loss of ankyrin-G in MDCK cells
--------------------------------------------------------------------

We next examined effects of knockdown of DHHC5 and -8 on subcellular localization of endogenous ankyrin-G and on cell height. In the DHHC5/8 double knockdown cells, ankyrin-G staining spread from the plasma membrane to the cytosol, in contrast to the single knockdown or control cells where ankyrin-G was confined to the lateral membrane ([Fig. 4, A and D](#fig4){ref-type="fig"}). Residual ankyrin-G staining on the lateral membrane may result from residual palmitoylation, which was only 90% complete, and/or interaction with E-cadherin and/or βII-spectrin. In addition, 110- and 120-kD cross-reacting polypeptides ([Fig. 4 B](#fig4){ref-type="fig"}) likely resulting from alternative splicing lack ANK repeats and are not subject to palmitoylation ([@bib48]; [@bib26]; [@bib24]). The loss of membrane staining was not caused by reduction of ankyrin-G expression level based on immunoblots of control and DHHC5/8 double knockdown cells ([Fig. 4, B and C](#fig4){ref-type="fig"}). Interestingly, the DHHC5/8 double knockdown cell monolayer exhibited a markedly reduced lateral membrane height ([Fig. 4, A \[the XZ plane\] and E](#fig4){ref-type="fig"}), thus phenocopying loss of ankyrin-G ([@bib34]; [@bib36]). This result is consistent with previous findings that ankyrin-G requires its palmitoylated cysteine 70 to restore the lateral membrane in ankyrin-G--depleted MDCK cells ([@bib24]).

![**Double knockdown of DHHC5 and -8 in MDCK cells causes disassociation of ankyrin-G from the plasma membrane and reduces lateral membrane height.** (A) The inducible shRNA cell lines were treated with doxycycline to knockdown indicated genes, and then were fixed for immunofluorescence (green, α-ankyrin-G; white, α--ZO-1). The profiles represent the α--ankyrin-G fluorescence intensities across the regions of interest indicated by the white arrows. Bars, 10 µm. (B) Representative Western blot showing ankyrin-G levels after silencing DHHC5 and -8. (C) Quantification of the normalized ankyrin-G level in DHHC5/8-silenced cells; mean ± SEM; student's *t* test; ns, not significant (P = 0.8); *n* = 4. (D) Quantification of the α--ankyrin-G fluorescence intensity ratio of plasma membrane to cytosol. Results were analyzed using one-way ANOVA and Tukey's tests; \*, P \< 0.001; *n* = 47--53. (E) Quantification of the lateral membrane height. Results were analyzed using one-way ANOVA and Tukey's tests; \*, P \< 0.001; *n* = 47--53.](JCB_201401016_Fig4){#fig4}

MDCK cells require millimolar concentrations of calcium to achieve apical--basolateral polarity and reversibly lose their polarity when transferred to a low calcium medium ([@bib42]). We previously reported that ankyrin-G remains on the plasma membrane in unpolarized MDCK cells exposed to low calcium, whereas its binding partners E-cadherin and βII-spectrin relocate to intracellular sites ([Fig. 5 A](#fig5){ref-type="fig"}; [@bib24]). In contrast, C70A ankyrin-G mutant, which is resistant to palmitoylation, also exhibited loss of plasma membrane staining in unpolarized MDCK cells ([@bib24]). Under the same low calcium condition, DHHC5 and -8 remain localized to the plasma membrane together with ankyrin-G ([Fig. 5 B](#fig5){ref-type="fig"}). Moreover, double knockdown of DHHC5 and -8 abolished the plasma membrane localization of ankyrin-G in unpolarized MDCK cells ([Fig. 5 C](#fig5){ref-type="fig"} and Fig. S1 E). These results together with loss of membrane association by the C70A ankyrin-G mutant demonstrate that palmitoylation of ankyrin-G by DHHC5/8 drives its association with the plasma membrane in unpolarized MDCK cells.

![**DHHC5/8 and ankyrin-G are required for lateral membrane reassembly after calcium switch.** (A) Ankyrin-G persists on the plasma membrane in unpolarized MDCK cells. Polarized MDCK cells were trypsinized and grown in Ca^2+^-depleted medium for 24 h before fixation (−Ca^2+^) or switched back to regular medium for another 24 h (+Ca^2+^). Samples were stained against ankyrin-G, ZO-1, E-cadherin, or βII-spectrin. (B) GFP-DHHC5 and -8 colocalize with ankyrin-G in unpolarized MDCK cells (green, α-GFP; red, α-ankyrin-G. (C) DHHC5/8-silenced cells or control cells (Luc-shRNA) were plated in Ca^2+^-depleted medium and fixed to stain against endogenous ankyrin-G. (D) DHHC5/8 or ankyrin-G--silenced cells fail to reassemble the lateral membrane after calcium switch. Stable shRNA cells were induced by to knockdown-indicated genes, and then plated in Ca^2+^-depleted medium. 24 h later, cells were switched back to regular medium and fixed at different time points: 2, 4, 8, 16, and 24 h (green, α-E-cadherin; white, α--ZO-1). Bars, 10 µm. (E) Quantification of the lateral membrane heights; mean ± SEM; *n* = 17--31.](JCB_201401016_Fig5){#fig5}

We next compared effects of knockdown of either DHHC5/8 or 210-kD ankyrin-G on lateral membrane reassembly after restoration of calcium. Control cells (Luc-shRNA) experienced rapid biosynthesis of the lateral membrane and grew from ∼2 to 8 µm in height within 24 h. In contrast, cells depleted of either 210-kD ankyrin-G or DHHC5/8 failed to restore lateral membrane height and grew from 2 to only 3 µm over the same period ([Fig. 5, D and E](#fig5){ref-type="fig"}; and [Fig. 6 C](#fig6){ref-type="fig"} for extent of 210-kD ankyrin-G knockdown). We also showed that during the repolarization process, there was no significant change of DHHC5 and -8 protein level (Fig. S1, C and D). However, loss of 210-kD ankyrin-G or DHHC5/8 did not affect the establishment of cell polarity, indicated by unaltered tight junction staining for ZO-1 and lateral membrane staining for E-cadherin ([Fig. 5 D](#fig5){ref-type="fig"}). Cells depleted of either ankyrin-G or DHHC5/8 still maintained a residual lateral membrane of ∼3 µm. The remaining lateral membrane may result from incomplete knockdown as detectable levels of ankyrin-G as well as DHHC5/8 persist in shRNA-expressing cells ([Fig. 3, H and I](#fig3){ref-type="fig"}; and [Fig. 6 C](#fig6){ref-type="fig"}). Alternatively, the residual height of 2--3 µm may represent lateral membrane that is independent of the ankyrin-G--DHHC5/8 pathway.

![**Ankyrin-G determines the polarized recruitment of βII-spectrin to the lateral membrane.** (A) Immunostaining of endogenous proteins in Luc-shRNA control cells (green, α--ankyrin-G; red, α-βII-spectrin; white, α--ZO-1). (B) Ankyrin-G--shRNA cells were induced to knockdown endogenous ankyrin-G and transfected with GFP, WT-AnkG-GFP, C70A-AnkG-GFP, DAR999AAA-AnkG-GFP, or DAR999AAA/C70A-AnkG-GFP, and then fixed for immunostaining (green, α-GFP; red, α-βII-spectrin; white, α--ZO-1). Asterisks indicate transfected cells. Bars, 10 µm. (C) The representative Western blot showing ankyrin-G knockdown efficiency. (D) Quantification of the height of lateral membranes and the apical mislocalization of endogenous βII-spectrin under each experimental condition. Results were analyzed using one-way ANOVA and Tukey's tests; \*, P \< 0.001; mean ± SEM; *n* = 17--23.](JCB_201401016_Fig6){#fig6}

βII-Spectrin requires both ankyrin-G and phosphoinositides for lateral membrane targeting
-----------------------------------------------------------------------------------------

Results so far demonstrate that palmitoylation of ankyrin-G by DHHC5/8 is required for targeting ankyrin-G to the lateral membrane as well as for reassembly of the lateral membrane after restoration of calcium to unpolarized MDCK cells. We next addressed the role of ankyrin-G in targeting βII-spectrin to the lateral membrane. βII-Spectrin potentially can associate with plasma membranes either through its ankyrin-binding site ([@bib11]; [@bib30]) and/or through a PH domain that binds to phosphoinositide lipids ([@bib28]; [@bib60]; [@bib61]; [@bib9], [@bib10]). Analysis of epistatic relationships between β-spectrin and the two ankyrin genes in *Drosophila* *melanogaster* indicate cell type--specific variations in use of PH domains and ankyrin-binding activities ([@bib9], [@bib10]; [@bib19]; [@bib43]). We therefore wanted to determine how βII-spectrin assembles on the lateral membrane in MDCK cells.

We first examined the effects of silencing ankyrin-G on the localization of endogenous βII-spectrin. In control cells, both ankyrin-G and βII-spectrin primarily localize to the lateral membrane ([Fig. 6 A](#fig6){ref-type="fig"}), which is consistent with previous findings ([@bib36]). Interestingly, in the absence of ankyrin-G, βII-spectrin mislocalized to the apical membrane in MDCK cells ([Fig. 6 B](#fig6){ref-type="fig"}, top). We next addressed the contributions of ankyrin-G binding and palmitoylation on βII-spectrin localization by evaluating mutation of ankyrin-G that abolishes its binding to βII-spectrin (DAR999AAA) or its palmitoylation (C70A). In each set of experiments, native 210-kD ankyrin-G was knocked down and replaced with either GFP-tagged wild-type (WT) or mutated proteins. We used the same approach of doxycycline-inducible knockdown as used with DHHC5 and -8 (see Materials and methods; [Fig. 3](#fig3){ref-type="fig"}) to achieve inducible loss of 80--90% of native 210-kD ankyrin-G ([Fig. 6 C](#fig6){ref-type="fig"}). Cells induced for shRNA expression were subsequently transfected within 24 h with GFP-tagged 190-kD ankyrin-G or βII-spectrin (see Materials and methods). 190-kD ankyrin-G and the native 210-kD ankyrin-G differ in that 210-kD ankyrin-G contains additional residues in the C-terminal regulatory domain (unpublished data). However, 190- and 210-kD ankyrin-G do not exhibit any difference in localization or ability to restore the lateral membrane in MDCK cells (unpublished data).

GFP-tagged WT ankyrin-G rescued the lateral membrane, as well as the polarity of endogenous βII-spectrin ([Fig. 6, B and D](#fig6){ref-type="fig"}, WT). However, DAR999AAA mutation of ankyrin-G that abolishes its binding to spectrin ([@bib36]; [@bib30]; [@bib29]) lost activity in restoring the lateral membrane in ankyrin-G--silenced cells ([@bib36]) as well as polarity of endogenous βII-spectrin ([Fig. 6, B and D](#fig6){ref-type="fig"}, DAR999AAA). Interestingly, DAR999AAA ankyrin-G still maintained its polarized localization at the residual lateral membrane, presumably because of palmitoylation and/or interaction with E-cadherin ([Fig. 6 B](#fig6){ref-type="fig"}, DAR999AAA). Similarly, the C70A mutation of ankyrin-G that abolishes its palmitoylation also failed to rescue the lateral membrane ([@bib24]) and the polarity of βII-spectrin ([Fig. 6, B and D](#fig6){ref-type="fig"}, C70A). In DHHC5/8-shRNA cells, βII-spectrin also mislocalized to the apical membranes ([Fig. S2 E](http://www.jcb.org/cgi/content/full/jcb.201401016/DC1){#supp2}), which is consistent with our hypothesis that palmitoylation of ankyrin-G plays a role in the polarity of βII-spectrin localization. The endogenous βII-spectrin persists on apical and lateral plasma membranes instead of relocating in the cytoplasm together with C70A ankyrin-G, which still maintains βII-spectrin binding activity (Fig. S2, A and B). We also found that the double mutant (DAR999AAA/C70A), which loses both palmitoylation and spectrin binding activity, behaved similarly to the C70A ankyrin-G ([Fig. 6, B and D](#fig6){ref-type="fig"}, DAR999AAA/C70A).

The finding that DAR999AAA ankyrin-G mutant remains on the lateral membrane ([Fig. 6, B and D](#fig6){ref-type="fig"}) suggests that ankyrin-G does not require βII-spectrin for targeting to the lateral membrane. To further test this conclusion, we evaluated the localization of endogenous ankyrin-G in the absence of βII-spectrin ([Fig. 7 A](#fig7){ref-type="fig"}). Consistently, in βII-spectrin knockdown cells, ankyrin-G remains on the lateral membrane ([Fig. 7, E and F](#fig7){ref-type="fig"}, WT). Mutation of a highly conserved tyrosine located in a surface-exposed loop within the 15th repeat of β-spectrins disrupts their interaction with ankyrins ([@bib36]; [@bib30]; [@bib29]; [Fig. 7, B and C](#fig7){ref-type="fig"}). We confirmed that the Y1874A mutation increased the dissociation constant of βII-spectrin for ankyrin-G from 10--20 nM to \>200 nM, and thus reduced the affinity by at least eightfold ([Fig. 7 D](#fig7){ref-type="fig"}). In addition, we also confirmed that this mutant still retained the same lipid-binding activity as WT βII-spectrin (Fig. S2 D). GFP-tagged Y1874A βII-spectrin was mislocalized to the apical membrane and also failed to restore the lateral membrane height compared with the WT ([Fig. 7, E and F](#fig7){ref-type="fig"}, Y1874A). This is consistent with our finding that endogenous βII-spectrin requires ankyrin-G to maintain its polarized targeting to the lateral membrane ([Fig. 6, B and D](#fig6){ref-type="fig"}).

![**Interaction between Ankyrin-G and βII-spectrin determines their dynamics on the plasma membrane but is dispensable for ankyrin-G targeting.** (A) The representative Western blot showing βII-spectrin knockdown efficiency. (B) The schematic diagram of GFP--βII-spectrin construct with precision protease site (CHD, calponin homology domain; ABD, ankyrin-binding domain; PHD, PH domain). (C) The atomic structure of βII-spectrin's ankyrin-binding domain; residue Y1874 is highlighted in yellow. (D) The protein binding curve of ankyrin-G with WT βII-spectrin or the Y1874A mutant; *n* = 2. (E) βII-spectrin--shRNA cells were induced to knockdown endogenous βII-spectrin and transfected with GFP, GFP--βII-spectrin WT, or GFP--βII-spectrin Y1874A, and then fixed for immunostaining (green, α-GFP; red, α--ankyrin-G; white, α--ZO-1). Bars, 10 µm. (F) Quantification of the height of lateral membranes and the apical mislocalization of endogenous ankyrin-G under each experimental condition. Results were analyzed using one-way ANOVA and Tukey's tests; \*, P \< 0.001; mean ± SEM; *n* = 21--27. (G) FRAP shows the dynamics of GFP-tagged WT βII-spectrin or the Y1874A mutant and GFP-tagged WT ankyrin-G or the DAR999AAA mutant on the lateral membrane (*n* = 6--11).](JCB_201401016_Fig7){#fig7}

We then performed FRAP experiments to examine whether loss of ankyrin-G--βII-spectrin interaction affects their higher-order assembly into stabilized structures. Indeed, the Y1874A GFP--βII-spectrin exhibited a marked increase in dynamics on the lateral membrane compared with the WT GFP--βII-spectrin ([Fig. 7 G](#fig7){ref-type="fig"}), affecting both the extent of recovery (55% for WT and 86% for Y1874A) and half-life (36 s for WT and 17 s for Y1874A). Even though ankyrin-G does not require binding to βII-spectrin to maintain its polarized localization based on our immunofluorescence study, it does require βII-spectrin binding for its proper dynamics ([Fig. 7 G](#fig7){ref-type="fig"}; recovery percentage: WT 38% and DAR999AAA 80%; half-life: WT 40 s and DAR999AAA 32 s). These results indicate that ankyrin-G and βII-spectrin depend on each other for their dynamics and function in MDCK cells.

The nonpolarized plasma membrane association of Y1874A βII-spectrin is likely caused by its PH domain because the βII-spectrin PH domain fused to GFP also associates generically with all plasma membrane surfaces ([Fig. 8 D](#fig8){ref-type="fig"}). We next addressed the role of phosphoinositide recognition by the PH domain of βII-spectrin. Basic residues in the PH domain of β-spectrin required for binding to inositol (1,4,5)P~3~ have been identified using nuclear magnetic resonance and other methods ([@bib28]; [@bib49]). Moreover, mutation of a basic PH domain residue eliminated binding of *Drosophila* β-spectrin to PI(4,5)P~2~ ([@bib10]). We confirmed that K2207Q mutation in the PH domain of βII-spectrin abolished binding affinity for phosphoinositides based on loss of interaction with lipid strips and liposomes containing various phosphoinositide lipids ([Fig. 8 C](#fig8){ref-type="fig"} and Fig. S2 C). WT βII-spectrin also associated with PI(3,4)P~2~ and PI(3,4,5)P~3~ in addition to PI(4,5)P~2~, and these interactions were also eliminated by the K2207Q mutation.

![**βII-Spectrin targets to the plasma membrane through its PH domain by binding to multiple phosphoinositide lipids.** (A) The schematic diagram of K2207Q GFP--βII-spectrin. (B) The atomic structure of the PH domain (PHD); the key residue required for phosphoinositide binding is highlighted in yellow. (C) The blots and quantification show the binding affinity of WT βII-spectrin or K2207Q mutant to different phosphatidylinositol-labeled liposomes (PI(3,4)P~2~, PI(4,5)P~2~, PI(3,4,5)P~3~, and PIPN(control)); *n* = 3. (D) The PH domain of βII-spectrin is sufficient to target to the plasma membrane. 25 ng of plasmids was transfected into MDCK cells grown on 14-mm MatTek plates. Top, the XZ plane; bottom, the XY plane. (E) βII-Spectrin knockdown cells were transfected with K2207Q GFP--βII-spectrin (green, α-GFP; red, α--ankyrin-G; white, α--ZO-1). (F) Quantification of lateral membrane heights rescued by WT or K2207Q GFP--βII-spectrin. Results were analyzed using Student's *t* test; \*, P \< 0.001; *n* = 19--21. (G) 1 µg of plasmids encoding PH domain from PLCδ1 (GFP-PLCδ1-PHD) or βII-spectrin (GFP--βII-spectrin--PHD) was transfected in MDCK cells grown on 14-mm MatTek plates (green, α-GFP; red, α--βII-spectrin). Bars, 10 µm. (H) Quantification of the height of lateral membranes and the disassociation of endogenous βII-spectrin from plasma membrane under each experimental condition. Results were analyzed using one-way ANOVA and Tukey's tests; \*, P \< 0.001; mean ± SEM; *n* = 31--36.](JCB_201401016_Fig8){#fig8}

The K2207Q βII-spectrin mutant exhibited a striking loss of association with the plasma membrane and remained intracellular ([Fig. 8 E](#fig8){ref-type="fig"}), whereas endogenous ankyrin-G under these conditions remains on the residual lateral membrane. The K2207Q βII-spectrin mutant also failed to restore the lateral membrane height ([Fig. 8, E and F](#fig8){ref-type="fig"}). This loss of plasma membrane targeting of K2207Q βII-spectrin, which still retains ankyrin-G binding activity (Fig. S2, A and B), is not consistent with a simple linear assembly pathway. Instead, βII-spectrin association with ankyrin-G on the lateral membrane is somehow coupled to interactions of its PH domain with phosphoinositide lipids. The dual requirement of βII-spectrin for both ankyrin and phosphoinositide lipids may explain some of the complexity noted in earlier analysis of relationships between ankyrins and spectrin in *Drosophila* ([@bib10]).

In our lipid binding assays, even though βII-spectrin showed the highest binding activity with PI(4,5)P~2~ lipids, it also bound to PI(3,4)P~2~ and PI(3,4,5)P~3~ and the binding to these lipids is abolished by the K2207Q mutation ([Fig. 8 C](#fig8){ref-type="fig"}). Because PI(4,5)P~2~ is enriched in the apical domain, whereas PI(3,4,5)P~3~ confers basolateral membrane identity in some epithelial cell models ([@bib20]; [@bib41]; [@bib54]), we next decided to examine whether βII-spectrin acts through PI(4,5)P~2~. Overexpression of the PH domain from phospholipase C δ1, which specifically binds to PI(4,5)P~2~ but not PI(3,4)P~2~ or PI(3,4,5)P~3~ ([@bib50]), showed strong apical localization but was not excluded from lateral membranes ([Fig. 8 G](#fig8){ref-type="fig"}). Overexpression of this PI(4,5)P~2~-specific PH domain showed no significant defects in either the lateral localization of βII-spectrin or the cell height ([Fig. 8, G and H](#fig8){ref-type="fig"}). However, overexpression of the PH domain from βII-spectrin showed no enrichment on the apical membrane ([Fig. 8 G](#fig8){ref-type="fig"}). More interestingly, overexpression of the βII-spectrin PH domain disrupted the plasma membrane localization of βII-spectrin and also significantly reduced the membrane height ([Fig. 8, G and H](#fig8){ref-type="fig"}). Together these findings suggest that βII-spectrin requires PI(3,4)P~2~ and PI(3,4,5)P~3~ but not PI(4,5)P~2~ for its lateral membrane localization and function.

DHHC5/8, ankyrin-G, and βII-spectrin colocalize in micrometer-scale membrane subdomains
---------------------------------------------------------------------------------------

We next examined the spatial relationships among DHHC5/8, ankyrin-G, and βII-spectrin in the lateral membrane using 3D deconvolution to improve resolution of confocal microscopy ([@bib55]; [@bib53]; [@bib7]). To evaluate DHHC5/8 and native ankyrin-G at steady-state, MDCK cells were transfected with GFP-DHHC5 or 8, fixed, and costained with antibodies against GFP and ankyrin-G. After 3D restoration and deconvolution of a selected lateral membrane region ([Fig. S3 A](http://www.jcb.org/cgi/content/full/jcb.201401016/DC1){#supp3}), we observed subdomains containing DHHC5/8 or ankyrin-G that ranged in size from 0.5--2 µm^2^ ([Fig. 9 A](#fig9){ref-type="fig"}). We further confirmed this micropattern by examining live cells expressing GFP-tagged ankyrin-G or βII-spectrin (Fig. S3, B and C). In contrast, subdomains were not observed in live cells incubated with small lipophilic probes, which uniformly labeled the lateral membrane (Fig. S3 D).

![**DHHC5/8 and βII-spectrin colocalize with ankyrin-G in microdomains.** The immunostaining of DHHC5/8, βII-spectrin, or ankyrin-G on the lateral membrane was analyzed using 3D deconvolution method in Volocity Image Analysis Software. Shown here are the en face views of the lateral membrane. Bars, 5 µm. (A) GFP-tagged DHHC5 or 8 were transfected into MDCK cells (green, α-GFP; red, α--ankyrin-G). (B) WT or Y1874A GFP--βII-spectrin was expressed in βII-spectrin--silenced MDCK cells (green, α-GFP; red, α--ankyrin-G). (C) WT or DAR999AAA ankyrin-G--GFP was expressed in ankyrin-G--silenced MDCK cells (green, α-GFP; red, α-βII-spectrin). (D) DAR999AAA ankyrin-G--GFP and HA-DHHC5 were coexpressed in ankyrin-G--silenced MDCK cells (green, α-GFP; red, α-HA). (E) Quantification of the colocalization indicated by pearson coefficients. Student *t* test; \*, P \< 0.01; mean ± SEM; *n* = 4--7.](JCB_201401016_Fig9){#fig9}

Substantial populations of DHHC5 and -8 are copatterned with ankyrin-G--positive microdomains based on Pearson coefficients of 0.7 for DHHC5/ankyrin-G and 0.6 for DHHC8/ankyrin-G ([Fig. 9, A and E](#fig9){ref-type="fig"}). WT βII-spectrin also copatterned with ankyrin-G--positive microdomains ([Fig. 9 B](#fig9){ref-type="fig"}, WT). To further evaluate the colocalization between ankyrin-G and βII-spectrin, we replaced endogenous βII-spectrin with either WT or Y1874A mutant GFP--βII-spectrin. This colocalization of βII-spectrin with ankyrin-G required ankyrin--spectrin interaction because the Y1874A βII-spectrin mutant--ankyrin-G exhibited a markedly reduced Pearson coefficient of 0.3 compared with 0.8 for WT ankyrin-G--βII-spectrin ([Fig. 9, B and E](#fig9){ref-type="fig"}). However, Y1874A βII-spectrin mutant is still patterned into microdomains, probably through its PH domain or other unidentified protein interactions. Similarly, we replaced endogenous ankyrin-G with either WT or DAR999AAA ankyrin-G--GFP and evaluated their colocalization with endogenous βII-spectrin. DAR999AAA ankyrin-G and βII-spectrin showed significantly reduced colocalization with a Pearson coefficient of 0.3 compared with 0.8 for WT ankyrin-G ([Fig. 9, C and E](#fig9){ref-type="fig"}). We hypothesized that the colocalization of ankyrin-G and DHHC5 or -8 in those microdomains is mediated by palmitoylation. Because the C70A ankyrin-G showed minimal membrane localization in ankyrin-G knockdown cells ([Fig. 7 B](#fig7){ref-type="fig"}), it was not possible to examine the micropatterning of C70A ankyrin-G. However, when we examined the DAR999AAA ankyrin-G, which is still palmitoylated (unpublished data), it showed markedly reduced colocalization with DHHC5 ([Fig. 9, D and E](#fig9){ref-type="fig"}). This finding was surprising but consistent with the fact that cells require all the components and functional connection among DHHC5/8, ankyrin-G, and βII-spectrin to build the lateral membrane. Thus MDCK cells require both palmitoylation and protein interactions to properly assemble their microdomains.

The finding that DHHC5/8 and βII-spectrin are copatterned with ankyrin-G into highly organized microdomains suggests a model where ankyrin-G is locally palmitoylated at the lateral membrane, and in turn drives the polarized recruitment of βII-spectrin--phosphoinositide complexes ([Fig. 9](#fig9){ref-type="fig"}). Loss of ankyrin-G--βII-spectrin interactionas a result of mutation of either protein results in loss of ankyrin-G--βII-spectrin copatterning in those microdomains and failure to restore the epithelial lateral membrane. Thus recruitment of βII-spectrin to ankyrin-G microdomains is essential for its downstream functions in building lateral membranes.

Discussion
==========

This study identifies two critical inputs from lipids that together provide a rationale for how ankyrin-G and βII-spectrin selectively localize on lateral membranes of MDCK epithelial cells ([Fig. 10](#fig10){ref-type="fig"}). These experiments began with the observation that ankyrin-G is S-palmitoylated at a single conserved cysteine that is required for ankyrin-G function in assembling lateral membranes and axon initial segments ([@bib24]). Here, we identified DHHC palmitoyltransferases 5 and 8 as the DHHC family members required for ankyrin-G palmitoylation as well as its localization at the lateral membranes of polarized MDCK cells. We also found that βII-spectrin functions as a coincidence detector that requires recognition of both palmitoylated ankyrin-G and phosphoinositide lipids as a prerequisite for its localization to the lateral membrane ([Figs. 8](#fig8){ref-type="fig"} and [9](#fig9){ref-type="fig"}). DHHC5/8 and phosphoinositides thus ensure that ankyrin-G and βII-spectrin localize only on lateral plasma membranes and not in the cytosol or on other membrane surfaces. Loss of either DHHC5 or -8, interactions between ankyrin-G and βII-spectrin, or βII-spectrin recognition of phosphoinositide lipids all result in failure to build the lateral membrane, which underscores the functional importance of this pathway.

![**A DHHC5/8--ankyrin-G--βII-spectrin network is required to build lateral membranes of polarized MDCK cells.** The schematic view summarizes roles of DHHC5/8, ankyrin-G, and βII-spectrin in assembling the lateral membrane of columnar epithelial cells. DHHC5/8 are localized to the lateral membrane, where they palmitoylate ankyrin-G. βII-Spectrin requires coincidence detection of ankyrin-G and phosphoinositide lipids to ensure its precise lateral membrane localization. Loss of any of the components or the functional relationship results in reduced lateral membrane height.](JCB_201401016_Fig10){#fig10}

Our findings establish DHHC5 and -8 as critical determinants of polarity for ankyrin-G and βII-spectrin in MDCK cells. However, the mechanisms responsible for polarized localization of DHHC5 and -8 themselves at the lateral membrane remain to be elucidated. Both proteins are distinguished from other DHHC family members by an extended cytoplasmic domain ([@bib57]). However, substitution of the C-terminal domain of DHHC14 for that of DHHC5 does not abolish lateral membrane targeting of DHHC5 ([Fig. S4](http://www.jcb.org/cgi/content/full/jcb.201401016/DC1){#supp4}). Thus, important localization information resides in the N-terminal halves of DHHC5 and -8.

The finding that βII-spectrin requires both ankyrin-G and phosphoinositides to associate with the lateral membrane was unexpected given the high affinity of the ankyrin-G--βII-spectrin interaction ([Fig. 7 D](#fig7){ref-type="fig"}). In contrast to erythrocytes, where β-spectrin lacks a PH domain because of alternative splicing but is tightly bound to the plasma membrane through ankyrin ([@bib3]; [@bib8]; [@bib63]), in MDCK cells the ankyrin--spectrin protein interaction is somehow coordinated with protein--lipid interactions. An advantage of imposing a dual requirement for phosphoinositides in addition to ankyrin binding is to prevent association of β-spectrins with ankyrin at sites other than the plasma membrane.

A critical tool that we developed for this study was a method to generate inducible shRNA-mediated knockdown of protein expression in an entire population of MDCK cells. This permitted evaluation of the roles of ankyrin-G and βII-spectrin in assembling lateral membranes without interference caused by other cellular defects, including impaired cytokinesis caused by loss of ankyrin-G or βII-spectrin ([@bib27]). Previous research using a transient siRNA strategy that resulted in a nearly complete loss of ankyrin-G in human bronchial epithelial cells also led to a complete loss of the lateral membrane domain accompanied by intracellular accumulation of E-cadherin ([@bib34]; [@bib35],[@bib36]). However, we did not observe either complete loss of the lateral membrane or intracellular accumulation of E-cadherin in MDCK cells with 80--90% knockdown achieved with the inducible system. We conclude that the intracellular accumulation of E-cadherin likely was secondary to elimination of sites for exocytosis because of complete loss of lateral membranes rather than a failure of post-Golgi transport as originally proposed ([@bib35]).

Although DHHC5/8, ankyrin-G, and βII-spectrin are required for columnar morphology of MDCK cells and operate in the same pathway, the mechanism of action of these proteins in expanding the lateral membrane remains to be determined. One possibility is that a lateral membrane--associated spectrin-based actin skeleton provides mechanical support for epithelial monolayers by coupling to membrane-spanning cell adhesion molecules such as E-cadherin, which is an ankyrin-G partner ([@bib45],[@bib46]; [@bib36]). Another possibility is that an ankyrin-G--spectrin--actin skeleton promotes cell height by enhancing cell--cell contacts through retention of E-cadherin and prevention of its endocytosis. In support of this idea, E-cadherin polarity in MDCK cells depends on a motif in its cytoplasmic domain that contains both ankyrin-binding activity as well as embedded dileucine residues required to engage clathrin endocytosis ([@bib32]). E-cadherin likely can associate with either ankyrin-G or clathrin adaptors but not both at the same time, and thus is restricted to the lateral membrane by the ankyrin--spectrin skeleton. A surprising conclusion of our study is that E-cadherin interaction with ankyrin-G is not sufficient to recruit ankyrin-G to the lateral membrane, which also requires palmitoylation in addition to its protein interactions. However, once ankyrin-G concentrates at the lateral membrane it may be able to prevent participation of E-cadherin in endocytosis through competition for binding to the polarity motif. Interestingly, inhibition of endocytosis of the cell adhesion molecule Fas2 has been proposed as a mechanism for regulating cell height in *Drosophila* epithelia ([@bib21]).

We have observed for the first time that ankyrin-G and βII-spectrin are concentrated in microdomains ranging from 0.5 to 2 µm^2^ in the MDCK cell lateral membrane ([Fig. 9](#fig9){ref-type="fig"}), which is inconsistent with the conventional view of a uniform ankyrin--spectrin lattice as observed in the plasma membrane of erythrocytes ([@bib39]; [@bib4]; [@bib1]). We believe that microdomains are not an artifact of cell fixation or deconvolution software because we observe similar micro-patterning using live imaging with ankyrin-G--GFP and GFP--βII-spectrin as with fixed cells (Fig. S3, B and C). In contrast, imaging with a lipid probe reveals uniform labeling (Fig. S3 D). Moreover, the protein interaction--dependent colocalization between ankyrin-G and βII-spectrin demonstrates specificity in cosegregation of these proteins ([Fig. 9, B and C](#fig9){ref-type="fig"}). The ankyrin-G and βII-spectrin microdomains revealed by 3D deconvolution microscopy in our study are distinguishable from membrane lipid rafts, which normally are much smaller ([@bib38]; [@bib56]). Segregation of functionally related proteins into microdomains can provide a platform for proteins that interact with moderate affinity and require high local concentration to achieve complexes. The fact that DHHC5 and -8 colocalize with ankyrin-G in these microdomains suggests these microdomains are sites of palmitoylation of ankyrin-G.

In summary, we have identified functional interactions connecting palmitoyltransferases DHHC5 and -8 with their substrate ankyrin-G, ankyrin-G with its partner βII-spectrin, and βII-spectrin with phosphoinositide lipids that are all required to build lateral membranes of MDCK columnar epithelial cells. Given the rapidly reversible nature of palmitoylation ([@bib51]; [@bib40]; [@bib18]), as well as phosphoinositides synthesis and degradation ([@bib12]; [@bib54]), these new findings suggest that the ankyrin-G--βII-spectrin--based membrane skeleton is much more dynamic and subject to regulation than previously appreciated. Moreover, the regulatory network properties of this set of interactions in terms of positive and negative feedback and coincidence circuitry are important areas for future investigation. Finally, our findings reinforce an emerging view of plasma membrane identity determination by a combinatorial code based on highly dynamic protein and lipid variables rather than hard-wired stable protein assemblies.

Materials and methods
=====================

Plasmids
--------

The 23 HA-tagged mouse DHHC constructs (the DHHC cDNA sequences were cloned into pEF-BOS-HA backbone using BamHI cut sites and under control of pEF-1 α promoter) were a gift from M. Fukata (National Institute for Physiological Sciences, Okazaki, Japan). DHHC5 was subcloned into peGFP-C1 vector using SacII and BamHI cut sites; DHHC8 was subcloned into peGFP-C1 vector using SalI and BamHI cut sites; DHHC14 was subcloned into peGFP-N1 using HindIII and EcoRI cut sites. The WT ankyrin-G--GFP and mutants C70A and DAR999AAA were previously described ([@bib36]; [@bib24], [@bib25]) and the sequences were cloned into peGFP-N1 using EcoRI and SalI cut sites. The human βII-spectrin cDNA was subcloned into peGFP-C3 vector using HindIII and SacII cut sites and the mutations Y1874A and K2207Q were introduced by mutagenesis. For βII-spectrin purification, a prescission protease site (LEVLFQGP) was introduced between the GFP and start codon. The PH domain of human βII-spectrin (amino acids 2200--2305) was subcloned into peGFP-N1 using XhoI and SacII cut sites.

Reagents and antibodies
-----------------------

Palmitic acid, \[9,10-^3^H(N)\] (PerkinElmer); *N*-ethylmaleimide and hydroxylamine (Sigma-Aldrich); EZ-Link BMCC-Biotin (Thermo Fisher Scientific); Dynabeads with protein G and Lipofectamine 2000 transfection reagent (Invitrogen); and the QuikChange II XL Site-Directed Mutagenesis kit (Agilent Technologies) were used. Mouse α-HA monoclonal antibody (Santa Cruz Biotechnology, Inc.); rabbit α-GFP polyclonal antibody (laboratory generated); chicken α-GFP polyclonal antibody, rat α--E-cadherin monoclonal antibody (Abcam); rabbit or goat α--ankyrin-G polyclonal antibody (laboratory generated using the C-terminal domain as epitope); rabbit α--βII-spectrin polyclonal antibody (laboratory generated using repeat 4--9 as epitope); rabbit α-biotin polyclonal antibody, rabbit α-DHHC5 polyclonal antibody, and rabbit α-DHHC8 polyclonal antibody (Abcam); mouse α-GAPDH monoclonal antibody (Sigma-Aldrich); and mouse α--ZO-1 monoclonal antibody (Invitrogen) were used.

Metabolic radiolabeling
-----------------------

This assay was performed following the protocol previously described with a few modifications ([@bib17]). In brief, 10^6^ HEK293T cells were plated in the 6-well plates and transfected with 2 µg HA-DHHC plasmids plus 3 µg ankyrin-G--GFP plasmids. 20 h after transfection, the cells were incubated with DMEM supplemented with 5% dialyzed FBS for 1 h, then \[^3^H\]palmitic acid was added to the final concentration of 200 µCi/ml. After 4-h incubation, the cells were washed with PBS and lysed directly using 0.5 ml SDS-PAGE buffer (62.5 mM Tris-HCl, pH 6.8, 10% glycerol, 2% SDS, 0.001% bromophenol blue, and 10 mM DTT) and heated for 5 min at 70°C. The proteins were separated in 3.5--17.5% gradient polyacrylamide gels. For Western blotting, samples were transferred onto nitrocellulose membrane and probed with α-GFP or α-HA antibody. For autoradiography, the gels were treated with amplify fluorographic reagent, dried using cellophane membrane, and exposed to x-ray film at −80°C.

Generation of doxycycline-inducible shRNA MDCK cell lines
---------------------------------------------------------

The original pLKO-Tet-on lentiviral vector (Addgene) was modified by replacement of the puromycin resistant gene with fluorescent TagBFP and the internal ribosome entry site with P2A peptide (5′-GSGATNFSLLKQAGDVEENPGP-3′), which mediates cotranslational cleavage. After cloning the shRNA hairpin targeting genes of interest to the vector, lentivirus was generated following standard protocol ([@bib62]). On the day of infection, 0.5--10^6^ MDCK cells were mixed with virus and 8 µg/ml polybrene and plated in 6-well dishes. 16 h later, the cells were extensively washed to remove viral particles and then grown in DMEM and 10% FBS. The next day, cells were trypsinized and sorted for the brightest TagBFP population (∼1%), which can be maintained as a stable cell line. Hairpins used to target genes of interest were as follows: luciferase control (5′-GGAGATCGAATCTTAATGTGC-3′), dog ankyrin-G (5′-GCTAGAAGTAGCTAATCTCCT-3′), dog βII-spectrin (5′-GGTGCTATTACTATCTCAAGA-3′), dog DHHC5 (5′-GTGTCAGATGGGCAGATAACT-3′), dog DHHC8 (5′-ACCTGTCCAGGACCATCATGG-3′), and dog DHHC5/8 (5′-TGGGTGAACAACTGTATCG-3′).

RT-PCR
------

To examine the native transcription of DHHC5 and DHHC8 in MDCK cells, total RNA was isolated using standard TRIzol-based protocol, and cDNA was generated using SuperScript III First-Strand Synthesis System (Life Technologies). Primers used for gene amplification were dog GAPDH (forward: 5′-GGTGATGCTGGTGCTGAGTATGTTG-3′; reverse: 5′-AGTGGAAGCAGGGATGATGTTCTGG-3′), dog DHHC5 (forward: 5′-GGAGGATGAAGACAAGGAAGATGAC-3′; reverse: 5′-GCTACAGGGATGAAGAATAAGCCAG-3′), and dog DHHC8 (forward: 5′-GATGAGGACGAGGATAAGGAGGAC-3′; reverse: 5′-GATGACAGGGATGAAGAAGAGGC-3′).

Acyl-biotin exchange assay
--------------------------

This assay was previously described ([@bib24]). In brief, Luc-, DHHC5-, DHHC8-, or DHHC5/8-shRNA cells were induced by 4 µg/ml doxycycline for 3 d and then homogenized in the presence of 50 mM *N*-ethylmaleimide. 1% SDS was added to the lysates to increase ankyrin-G solubility. After sonication and centrifugation, Triton X-100 was added to a final concentration of 1% (vol/vol) to quench SDS. 60 µl of dynabeads preloaded with 10 µg α--ankyrin-G antibody were then incubated with the lysates overnight. The beads were then washed and incubated with hydrolysis-labeling buffer (1 M hydroxylamine/Tris as a control, 80 µM BMCC-biotin, 10 mM sodium phosphate, and 2 mM Na-EDTA, pH 7) at room temperature for 2 h. Beads were then washed and incubated with loading buffer (2% SDS, 10% glycerol, 40 mM Tris-HCl, 150 mM NaCl, 2 mM NaEDTA, and 200 mM DTT with Bromophenol blue). Samples were analyzed by SDS-PAGE and probed by immunoblotting with α--ankyrin-G or α-biotin antibodies. The total cell lysates were also collected and analyzed to confirm the knockdown efficiency of DHHC5 and -8.

Transfection and Immunofluorescence
-----------------------------------

To examine the subcellular localization of the 23 DHHC palmitoyltransferases, 10^5^ MDCK cells were plated in the insert of MatTek plates. The next day, cells were transfected with 80 ng of plasmids encoding HA- or GFP-DHHC using Lipofectamine. 48 h later, the cells were fixed by 4% PFA for 15 min, permeabilized by 0.4% Triton X-100 for 10 min, blocked by 5% BSA, and incubated with primary antibody overnight at 4°C. Alexa Fluor 488 and 568 were used for secondary antibody. To study the localization of ankyrin-G after silencing DHHC5, DHHC8, or DHHC5/8, cells were induced by 4 µg/ml doxycycline for one day and then replated on MatTek plates in the presence of doxycycline for another 2 d before fixation. Parallel samples were collected for Western blotting to study ankyrin-G levels. To stain endogenous βII-spectrin in MDCK cell, we used 1% PFA at 4°C for 1 h and then followed the protocol as described above.

Calcium switch assay and lateral membrane reassembly
----------------------------------------------------

The calcium switch assay was previously described ([@bib24]). Here we used this assay to study lateral membrane reassembly. Luc-, Ankyrin-G--, or DHHC5/8-shRNA cells were induced by 4 µg/ml doxycycline for 3 d, and then trypsinized and plated in calcium-depleted medium (DMEM, 5% dialyzed FBS, and 4 µg/ml doxycycline; 10^6^ cells in MatTek plates). The next day, the plates were washed slightly to remove unattached cells and then switched to regular medium (DMEM, 10% FBS, and 4 µg/ml doxycycline). Cells were then fixed at different time points (2, 4, 8, 16, and 24 h). To examine the localization of transfected GFP-DHHC5 and -8 in unpolarized MDCK cells, 100 ng DNA was transfected into MDCK cells following standard protocol. 6 h later, the cells were trypsinized and replated in calcium-depleted medium and kept for 24 h before fixation.

Lateral membrane rescue
-----------------------

10^7^ ankyrin-G--shRNA or βII-spectrin--shRNA cells were induced in 10-cm dishes in the presence of 4 µg/ml doxycycline for 16 h. Then 1.5 × 10^5^ preinduced cells were replated in MatTek plates. 8 h later, cells were washed and transfected with 100 ng of rescue plasmids (GFP, Ankyrin-G--GFP, or GFP--βII-spectrin) using the standard protocol. Cells were maintained in 4 µg/ml doxycycline and fixed 48 h after transfection.

Microscopy
----------

Imaging for fixed samples was performed at room temperature using an inverted confocal microscope (LSM780; Carl Zeiss) with camera (AxioCam MRm Rev.3) and 63×, NA 1.40, or 100×, NA 1.45 oil objective lenses. Secondary antibodies were conjugated with Alexa Fluor 488, 568, or 647. XZ planes were reconstructed from Z stacks with optical sections of 250 nm using ZEN 2012 software. For live imaging, the incubation chamber was maintained at 37°C, 5% CO~2~, and cells were maintained in growth medium (DMEM and 10% FBS). For 3D deconvolution microscopy, images were collected at room temperature using the 100×, NA 1.45, objective lens with optical sections of 250 nm and subjected to 3D deconvolution in Volocity 3D Image Analysis Software (PerkinElmer) with a point spread function (axial spacing in Z: 0.25 µm; lateral spacing in XY: 0.0277 µm; medium reference index: 1.52; NA 1.45; detector pinhole size: 1 Airy unit).

Expression and purification of βII-spectrin
-------------------------------------------

βII-spectrin was cloned into peGFP-C3 along with a precision protease site (LEVLFQGP) between the GFP and ATG of βII-spectrin. Mutations were made into the βII-spectrin sequence using site-directed mutagenesis (Agilent Technologies). WT βII-spectrin and mutants were transfected into 293T17 cells in 10-cm dishes using lipofectamine (Invitrogen). After 36 h, lysates were produced from each transfection and GFP--βII-spectrin was isolated using a rabbit anti-GFP antibody and pulled down using protein G dynabeads (Invitrogen). After extensive washing using high salt and Triton X-100, βII-spectrin was released from dynabeads using prescission protease enzyme (GE Healthcare).

Ankyrin-G--βII-spectrin binding assay
-------------------------------------

His-tagged ankyrin-G expressed in S9 cells was purified as previously described ([@bib35]). In brief, S9 cells expressing ankyrin-G--His using the pBacPak9 system were lysed in 50 mM phosphate buffer, 0.3 M NaBr, 20 mM imidazole, and 0.2 mM β-mercaptoethanol and coupled to nickel Sepharose (GE Healthcare). Sepharose was washed with binding buffer, and proteins were finally eluted in buffer containing 50 mM phosphate buffer, 0.3 M NaBr, and 70 mM imidazole. WT GFP--βII-spectrin and Y1874A GFP--βII-spectrin expressed and purified from HEK293 cells were immobilized using an antibody against GFP on protein G dynabeads and increasing concentrations of ankyrin-G--His were added to a final reaction volume of 200 µl in binding buffer (10 mM sodium phosphate, 75 mM NaCl, 1 mM DTT, 1 mM EDTA, 5% sucrose, and 4% BSA, pH 7.3). Bound and free ankyrin-G--His were separated by pelleting beads through a 20% sucrose cushion. The amount of bound ankyrin-G--His was determined through immunoblotting with α-His antibody followed by phosphorimage analysis. Data points were generated after normalization for βII-spectrin levels and nonspecific binding of ankyrin-G.

FRAP
----

300 ng of plasmids encoding WT or Y1874A GFP--βII-spectrin were transfected into βII-spectrin--silenced MDCK cells as described in Lateral membrane rescue. Similarly, WT or DAR999AAA ankyrin-G--GFP were transfected into ankyrin-G--silenced cells. The GFP signals were collected every 5 s for a 3-min period. At each time point, three regions were monitored: region 1 is the photobleached membrane area; region 2 is a membrane area of an adjacent transfected cell, which can be used to control the signal variability; region 3 is a nontransfected cell region, which is used to correct the background noise. The signal from region 1 was double normalized to that from regions 2 and 3, and then fitted to the exponential equation y = y~0~ + Ae^−kxt^.

Phosphatidylinositol binding assay
----------------------------------

We purchased phosphatidylinositol-labeled liposomes that contained a biotin tag from Echelon Biosciences. Liposomes for PIP~2~(3,4), PIP~2~(4,5), PIP~3~(3,4,5), and PIPN(control) were used at 10-µM concentration and incubated with purified WT βII-spectrin and K2207Q βII-spectrin in interaction buffer (50 mM Tris, 100 mM NaCl, 1 mM DTT, 5% sucrose, and 3% fatty acid--free BSA, pH 7.4). Bound βII-spectrin was separated from free βII-spectrin through pull-down of liposomes using streptavidin-labeled dynabeads. Levels of protein binding were determined by immunoblotting using α--βII-spectrin antibody and quantified through phosphorimager.

Data analysis
-------------

ImageJ was used to measure the fluorescence intensity of confocal microscopy images. To measure the mean intensity of the plasma membrane, a line was drawn along the plasma membrane and recorded. To measure the mean intensity of cytoplasm, an area of interest was draw within the cytoplasm and recorded. A Typhoon 9200 phosphorimager and Imagequant software (GE Healthcare) were used to quantify the intensity of Western blots. Student's *t* test was used to analyze two-group comparisons, and one-way analysis of variance (ANOVA) followed by Tukey's tests were used to perform multiple group comparisons. The tests were performed using Prism 5 software (GraphPad Software).

Online supplemental material
----------------------------

Fig. S1 A shows that C70A ankyrin-G is resistant to palmitoylation. Fig. S1 B shows that silencing DHHC5 does not up-regulate the level of DHHC8 and vice versa. Fig. S1 (C and D) shows that the protein level of DHHC5 or 8 is not altered during the polarization process of MDCK cells. Fig. S1 E shows that loss of DHHC5/8 results in plasma membrane dissociation of ankyrin-G in unpolarized MDCK cells. Fig. S2 (A and B) shows that C70A ankyrin-G and K2207Q βII-spectrin maintain their protein binding activities. Fig. S2 (C and D) shows that Y1874A βII-spectrin maintains its lipid binding activity. Fig. S2 E shows that βII-spectrin is mislocalized in DHHC5/8 silenced MDCK cells. Fig. S3 shows that the micropatterning of ankyrin-G or βII-spectrin exists in live cells. Fig. S4 shows that the C terminus of DHHC5 is not required for its lateral localization. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201401016/DC1>. Additional data are available in the JCB DataViewer at <http://dx.doi.org/10.1083/jcb.201401016.dv>.
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